Pulmonary hypertension (elevated pressure within the blood vessels of the lungs) is organized into five groups: Group 1: Pulmonary arterial hypertension (PAH) Group 2: Pulmonary venous hypertension (due to problems on the left side of the heart) Group 3: Pulmonary hypertension due to lung disease Group 4: Pulmonary hypertension due … [Read more...]
Lung Transplantation with PAH
For Pulmonary Arterial Hypertension (PAH) patients who remain very short of breath despite maximal medical therapy, lung transplantation may be an option. Maximal medical therapy usually means continuously infused therapy (Remodulin, Flolan, Veletri) and multiple oral medications. First, it is important to know that lung transplantation is not a … [Read more...]
Uptravi (Selexipag) for PAH
Uptravi was approved in 2016 to treat Pulmonary Arterial Hypertension, PAH. We now have more than four years of experience with this medication. There are three broad pathways that PAH medications impact. 3 Pathways PAH Medications Impact The endothelin pathway is overactive in PAH and leads to excessive blood vessel squeezing and … [Read more...]
Phase 1 Study of Stem Cells for Pulmonary Arterial Hypertension
Stem cells are special types of cells that have the ability to renew themselves and develop into different types of tissues. There are a variety of different types of stem cells but the general concept is that we all have a small reservoir of these cells in our bodies. These cells allow us to repair and replenish the cells that make up the different … [Read more...]
Is the Implanted Remodulin Pump Right for Me?
Excitement is building for the final release of the implanted system for Remodulin. After more than 8 years of study, we are poised to have this device available to patients. PAH patients across the country are eager to embrace the new pump and say goodbye to their Broviac/Hickman/Groshong catheter or their subcutaneous catheter and the associated site … [Read more...]
